IL22 and breast cancer: The IL-22 stimulation of MSCs increased the invasive potential of MDA-MB231 cells which was suppressed by the S1P antagonist (Figure 3F), again indicating that the IL-22 cytokine has a promoting effect on breast cancer cell migration and invasion via S1P signaling.